This quarter saw a 12% growth in revenue driven by net new business and strategic migrations from legacy products. Year-over-year performance also improved by 15% compared to the same quarter last year.
Net New Business remained the strongest driver of growth.
Renewals contributed roughly 40% to total revenue.
Migrations made up 10% of revenue but have room for expansion.
Quarterly Revenue Breakdown
Sales & Revenue Dynamics
Revenue distribution varied by region, with North America leading the pack at 55% of total revenue, followed by EMEA (30%) and a rapidly growing APAC region (15%).
Healthcare had a 20% QoQ increase in closed-won deals.
Government deals grew by 15%, largely in compliance-focused programs.
Large Enterprises contributed nearly 60% of total quarterly revenue.
Revenue by Region & Vertical
Sales Cycle Efficiency & Patterns
By excluding deals closed under 20 days, the average sales cycle stands at 2.5 months. Large Enterprise and Government deals require significantly longer timelines, but yield higher returns.
North America’s average sales cycle: 2.2 months.
EMEA: 3 months due to regulatory considerations.
APAC: 2.8 months, showing improvement with new market penetration.
Average Sales Cycle
Strategic Business Impact
The 5x3 Go-to-Market strategy and new price book influenced major gains in Healthcare and Government. APAC’s territory expansion also accelerated revenue with a 25% QoQ improvement.
Healthcare & Government bundles increased average deal size by 15%.
Net new deals up by 18%; expansion deals up by 30% in large accounts.
ERM, CAM, FSM structures are showing measurable efficiency gains.
Net New vs. Expansion Deals
Additional Executive-Level Insights
Unexpected slowdowns emerged in the Retail vertical, indicating potential market headwinds. However, overall momentum remains strong, backed by expansion opportunities in Healthcare, Government, and APAC.
Opportunity: Increase focus on compliance-heavy verticals.
Risk: Retail slump could persist into Q1 without targeted action.
Recommendation: Accelerate EMEA sales support and continue APAC enablement.
Next Steps: Investigate retail performance drivers, refine territory strategies, and invest further in healthcare cross-selling.